Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (281-290 of 688) with videos related to

Pageof 69
Sort By:
European Journal of Heart Failure|April 15, 2010
Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF)Faiez Zannad, John J V McMurray, Helmut Drexler, et al.
Circulation|October 1, 2003
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy studyBertram Pitt, Nathaniel Reichek, Roland Willenbrock, et al.
European Journal of Heart Failure|October 4, 2024
Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: The TRANSFORM-HF trialNina Nouhravesh, Stephen J Greene, Robert Clare, et al.
Journal of Cardiac Failure|May 29, 2012
Hypo- and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: data from EPHESUSChristian Ukena, Daniela Dobre, Felix Mahfoud, et al.
Journal of Hypertension|December 7, 2013
Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic functionSusan Cheng, Carolyn Lam, Amil Shah, et al.
Journal of the American College of Cardiology|April 12, 2023
Time to Benefit With Sotagliflozin in Patients With Worsening Heart FailureSubodh Verma, Deepak L Bhatt, Nitish K Dhingra, et al.
JACC. Heart Failure|November 3, 2022
Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTsJoão Pedro Ferreira, Bertram Pitt, John J V McMurray, et al.
European Journal of Heart Failure|March 3, 2020
Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failurePooja Dewan, Alice Jackson, Carolyn S P Lam, et al.
Cardiovascular Drugs and Therapy|July 23, 2011
Effect of aliskiren in patients with heart failure according to background dose of ACE inhibitor: a retrospective analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) trialNovalia P Sidik, Scott D Solomon, Roberto Latini, et al.
Circulation|December 1, 2011
Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival StudyPatrick Rossignol, John G F Cleland, Sunil Bhandari, et al.
Pageof 69

Showing results (281-290 of 688) with videos related to

Sort By:
Pageof 69
European Journal of Heart Failure|April 15, 2010
Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF)Faiez Zannad, John J V McMurray, Helmut Drexler, et al.
Circulation|October 1, 2003
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy studyBertram Pitt, Nathaniel Reichek, Roland Willenbrock, et al.
European Journal of Heart Failure|October 4, 2024
Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: The TRANSFORM-HF trialNina Nouhravesh, Stephen J Greene, Robert Clare, et al.
Journal of Cardiac Failure|May 29, 2012
Hypo- and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: data from EPHESUSChristian Ukena, Daniela Dobre, Felix Mahfoud, et al.
Journal of Hypertension|December 7, 2013
Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic functionSusan Cheng, Carolyn Lam, Amil Shah, et al.
Journal of the American College of Cardiology|April 12, 2023
Time to Benefit With Sotagliflozin in Patients With Worsening Heart FailureSubodh Verma, Deepak L Bhatt, Nitish K Dhingra, et al.
JACC. Heart Failure|November 3, 2022
Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTsJoão Pedro Ferreira, Bertram Pitt, John J V McMurray, et al.
European Journal of Heart Failure|March 3, 2020
Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failurePooja Dewan, Alice Jackson, Carolyn S P Lam, et al.
Cardiovascular Drugs and Therapy|July 23, 2011
Effect of aliskiren in patients with heart failure according to background dose of ACE inhibitor: a retrospective analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) trialNovalia P Sidik, Scott D Solomon, Roberto Latini, et al.
Circulation|December 1, 2011
Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival StudyPatrick Rossignol, John G F Cleland, Sunil Bhandari, et al.
Pageof 69